(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.41%) $83.51
(-1.16%) $1.619
(-0.06%) $2 345.90
(0.85%) $27.49
(0.28%) $924.70
(0.26%) $0.934
(0.42%) $11.00
(0.07%) $0.800
(0.00%) $92.17
Live Chart Being Loaded With Signals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia...
Stats | |
---|---|
आज की मात्रा | 4 000.00 |
औसत मात्रा | 388 433 |
बाजार मूल्य | 569.76M |
EPS | HKD0 ( 2023-08-28 ) |
Last Dividend | HKD0.00260 ( 2023-06-29 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -26.50 |
ATR14 | HKD0 (0.00%) |
Tianda Pharmaceuticals सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Tianda Pharmaceuticals वित्तीय
Annual | 2023 |
राजस्व: | HKD532.09M |
सकल लाभ: | HKD255.53M (48.02 %) |
EPS: | HKD-0.0112 |
FY | 2023 |
राजस्व: | HKD532.09M |
सकल लाभ: | HKD255.53M (48.02 %) |
EPS: | HKD-0.0112 |
FY | 2022 |
राजस्व: | HKD546.69M |
सकल लाभ: | HKD251.52M (46.01 %) |
EPS: | HKD-0.0254 |
FY | 2022 |
राजस्व: | HKD509.96M |
सकल लाभ: | HKD241.22M (47.30 %) |
EPS: | HKD-0.0101 |
Financial Reports:
No articles found.
Tianda Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0112 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.00260 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00450 | 2010-07-23 |
Last Dividend | HKD0.00260 | 2023-06-29 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD0.0530 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.23 | -- |
Div. Sustainability Score | 4.25 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 1.955 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2289.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
1277.HK | Ex Dividend Knight | 2023-10-09 | Semi-Annually | 0 | 0.00% | |
0335.HK | Ex Dividend Knight | 2023-09-04 | Annually | 0 | 0.00% | |
6069.HK | Ex Dividend Junior | 2023-06-28 | Annually | 0 | 0.00% | |
1836.HK | Ex Dividend Knight | 2023-09-06 | Annually | 0 | 0.00% | |
0861.HK | Ex Dividend Junior | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
0012.HK | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
2611.HK | Ex Dividend Junior | 2023-06-09 | Annually | 0 | 0.00% | |
1402.HK | Ex Dividend Junior | 2023-08-10 | Sporadic | 0 | 0.00% | |
0480.HK | Ex Dividend Knight | 2023-08-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0454 | 1.500 | -0.908 | -1.362 | [0 - 0.5] |
returnOnAssetsTTM | -0.0263 | 1.200 | -0.878 | -1.053 | [0 - 0.3] |
returnOnEquityTTM | -0.0405 | 1.500 | -1.561 | -2.34 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.099 | 0.800 | 9.51 | 7.61 | [1 - 3] |
quickRatioTTM | 0.854 | 0.800 | 9.68 | 7.75 | [0.8 - 2.5] |
cashRatioTTM | 0.518 | 1.500 | 8.23 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.120 | -1.500 | 7.99 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -5.45 | 1.000 | -3.13 | -3.13 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0241 | 2.00 | -0.00802 | -0.0160 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0424 | 2.00 | -0.0212 | -0.0424 | [0 - 20] |
debtEquityRatioTTM | 0.187 | -1.500 | 9.25 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.480 | 1.000 | 5.33 | 5.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0545 | 1.000 | -3.09 | -3.09 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.468 | 1.000 | -3.71 | -3.71 | [0.2 - 2] |
assetTurnoverTTM | 0.580 | 0.800 | 9.47 | 7.57 | [0.5 - 2] |
Total Score | 4.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -23.59 | 1.000 | -2.48 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0405 | 2.50 | -1.003 | -2.34 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0424 | 2.00 | -0.0141 | -0.0424 | [0 - 30] |
dividendYielPercentageTTM | 0.981 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0241 | 2.00 | -0.00802 | -0.0160 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.156 | 1.500 | -2.30 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0972 | 1.000 | -4.93 | 0 | [0.1 - 0.5] |
Total Score | -0.341 |
Tianda Pharmaceuticals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं